摘要
静脉血栓栓塞症(VTE)是可预防程度最高的致死性疾病之一,准确的风险评估对其预防至关重要。传统VTE风险评估主要由医护人员完成,耗时费力。近年来,患者自我评估的研究逐渐受到关注。本文探讨患者自我评估VTE风险的可行性、有效性及其应用前景。通过对多项研究的整理和分析,发现基于患者自我评估模式的Caprini静脉血栓风险评估量表在不同语言版本和患者群体中呈现出一定的有效性,可显著提升评估效率,促进患者健康关注度和参与度,可以作为医护人员评估的有效补充,但患者自我评估过程中部分评估选项容易出现认知偏差,特殊疾病患者独立完成自评的难度较大,因此未来需进一步优化评估工具,借助新技术实现评估自动化和智能化,并开展多中心、大样本的高质量研究,以提高VTE风险评估的准确性和效率,促进患者参与和临床实践的改善。
Venous thromboembolism(VTE)is one of the most preventable fatal diseases,and accurate risk assessment is crucial for its prevention.Traditionally,VTE risk assessment has been predominantly conducted by healthcare providers,which is time-consuming and laborious.In recent years,research on patient self-assessment has increasingly attracted attention.This article mainly discusses the feasibility,effectiveness,and application prospects of patient self-assessment of VTE risk.Through the collation and analysis of multiple studies,it was found that the the Caprini risk score of venous thromboembolism based on the patient self-assessment model had shown certain effectiveness in different language versions and patient groups.It can significantly improve the efficiency of assessment,promote patients′attention to health and participation,and can be used as an effective supplement to the assessment of medical staff.However,during the patient self-assessment process,cognitive biases are prone to occur in some assessment options,and it is difficult for patients with special disease conditions to independently complete self-assessment.Therefore,in the future,it is necessary to further optimize assessment tools,leverage new technologies to achieve automated and intelligent assessment,and carry out high-quality multi-center and large-sample studies to improve the accuracy and efficiency of VTE risk assessment,and promote patient participation and improvement of clinical practice.
作者
夏磊
陈兆斐
翟振国
Xia Lei;Chen Zhaofei;Zhai Zhenguo(Medical Department of China-Japan Friendship Hospital,Respiratory Experimental Research Department,Center of Respiratory Medicine,China-Japan Friendship Hospital,Beijing 100029,China National Center for Respiratory Medicine;State Key Laboratory of Respiratory Health and Multimorbidity,National Clinical Research Center for Respiratory Diseases,Institute of Respiratory Medicine,Chinese Academy of Medical Sciences,Department of Pulmonary and Critical Care Medicine,Center of Respiratory Medicine,China-Japan Friendship Hospital,Beijing 100029,China)
出处
《中华医学杂志》
北大核心
2025年第30期2531-2535,共5页
National Medical Journal of China
基金
国家重点研发计划(2023YFC2507200)
中央高水平医院临床科研业务费(2022-NHLHCRF-LX-01-0108)
中国医学科学院医学与健康科技创新工程(2021-I2M-1-061)
中国医学科学院临床与转化医学研究专项(2023-I2M-C&T-A-014)。
